Pluri Inc. — Director's Dealing 2020

Jun 29, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2020-05-27

Reporting Person: CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-27	Common Stock	P	90000	$8.14	Acquired	2601311	Direct
2020-05-28	Common Stock	P	75898	$8.16	Acquired	2677209	Direct
2020-05-31	Common Stock	P	1797	$7.95	Acquired	2679006	Direct
2020-06-01	Common Stock	P	22796	$7.85	Acquired	2701802	Direct
2020-06-02	Common Stock	P	117489	$7.57	Acquired	2819291	Direct
2020-06-04	Common Stock	P	7610	$7.86	Acquired	2826901	Direct
2020-06-05	Common Stock	P	60000	$7.82	Acquired	2886901	Direct
2020-06-08	Common Stock	P	178717	$7.36	Acquired	3065618	Direct
2020-06-09	Common Stock	P	72142	$7.15	Acquired	3137760	Direct
2020-06-10	Common Stock	P	25000	$6.91	Acquired	3162760	Direct
2020-06-18	Common Stock	P	49000	$7.36	Acquired	3211760	Direct

Footnotes

F1: The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $8.02 to $8.25 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

F2: The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $7.90 and $8.26 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

F3: The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at $7.922485038 and $7.973781704 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

F4: The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at $7.81 and $7.88 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

F5: The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $7.25 to $7.92 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

F6: The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $7.70 to $7.9994 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

F7: The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $7.30 to $7.97 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

F8: The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $7.05 to $7.42 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

F9: The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at $6.90 and $6.95 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

F10: The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $7.2882 to $7.4119 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.